SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-027256
Filing Date
2022-08-01
Accepted
2022-08-01 16:05:46
Documents
7
Period of Report
2022-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20220727.htm 8-K 55265
2 EX-1.1 maia-ex11_7.htm EX-1.1 450791
3 EX-3.1 maia-ex31_8.htm EX-3.1 35766
4 EX-3.2 maia-ex32_6.htm EX-3.2 192515
5 EX-10.1 maia-ex101_10.htm EX-10.1 77280
6 EX-99.1 maia-ex991_9.htm EX-99.1 9284
7 EX-99.2 maia-ex992_172.htm EX-99.2 9205
  Complete submission text file 0001564590-22-027256.txt   831353
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 221124758
SIC: 2834 Pharmaceutical Preparations